Celldex completes follow-on

Celldex Therapeutics Inc. (NASDAQ:CLDX), Needham, Mass. Business: Cancer, Infectious, Renal Date completed: 2/24/12 Type: Follow-on Raised: $40.4 million Shares: 10.5 million Price: $3.85 Shares after...